WhatsApp
backNews Article

Yatharth Hospital Raises INR 31,500 Million via 24.87% Stake Sale to Cyprus Investor Rasmalai Limited

The Competition Commission of India approves preferential issue; transaction pending further regulatory clearances

Yatharth Hospital & Trauma Care Services Limited has received Competition Commission of India approval for a preferential issue raising INR 31,500 million from Rasmalai Limited, acquiring 24.87% post-issue stake. The investment is subject to other regulatory clearances and represents a significant minority holding by the foreign investor.

7 days ago|YATHARTH+1.15%
Yatharth Hospital & Trauma Care Services LimitedYATHARTHPreferential Issue

Yatharth Hospital & Trauma Care Services Limited

Preferential Issue

Yatharth Hospital & Trauma Care Services Limited announced approval from the Competition Commission of India for a preferential issue to Rasmalai Limited, a Cyprus-based investor, raising approximately INR 31,500 million for a 24.87% shareholding on a fully diluted basis.

The preferential issue involves the issuance and allotment of securities on a private placement basis exclusively to Rasmalai Limited, resulting in the investor acquiring a minority stake of 24.87% post-issue in the company.

While the Competition Commission of India has given its nod on November 10, 2026, the transaction remains subject to the fulfillment of other applicable regulatory and statutory requirements.

Details regarding the timing and completion of the allotment have not been disclosed in the filing.

The company updated shareholders and the market as per SEBI disclosure norms and has published relevant documents on its website.

Highlights

  • Preferential issue valued at approximately INR 31,500 million.
  • Rasmalai Limited to acquire 24.87% post-issue shareholding on fully diluted basis.
  • Approval obtained from Competition Commission of India dated November 10, 2026.
  • Subject to other regulatory and statutory approvals before completion.
  • Announcement made under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Data Snapshot

Investment amountINR 31,500 million
InvestorRasmalai Limited
Investor country of incorporationCyprus
Stake acquired24.87% of post-issue share capital on fully diluted basis
CCI approval dateNovember 10, 2026
Filing dateNovember 12, 2026

What happened

  • Yatharth Hospital received approval from the Competition Commission of India for a preferential issue of equity shares.
  • The issuance is made on a private placement basis to Rasmalai Limited, a Cyprus-incorporated entity.
  • This investment amounts to INR 31,500 million in cash consideration.
  • Post-issue, Rasmalai Limited will hold a 24.87% minority stake on a fully diluted basis.

Key details

  • The transaction is subject to the fulfillment of other applicable regulatory and statutory requirements.
  • No further details on the timing or sequence of completion have been disclosed.
  • The announcement complies with SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.
  • Disclosure and supporting documents are available on the company's investor relations website.

Regulatory and governance context

  • The Competition Commission of India approved the preferential issue on November 10, 2026.
  • This approval is required under Indian competition laws to ensure the transaction does not raise anti-competitive concerns.
  • Completion depends on additional regulatory clearances beyond the CCI approval.

More News on Preferential Issue

View all

Latest corporate announcements and market updates in Preferential Issue.

View all news
Yatharth Hospital Raises INR 31,500 Million via 24.87% | Stockk News